|
A7766
|
|
N4-Acetylcytidine ≥98%
|
3768-18-1
|
285.3
|
|
|
|
|
A3390
|
|
3′-O-Acetyl-2′-deoxycytidine ~98%
|
72560-69-1
|
269.3
|
|
|
|
|
A9730
|
|
Adefovir dipivoxil
|
142340-99-6
|
501.5
|
|
|
|
|
A2026
|
|
Allopurinol riboside
|
16220-07-8
|
268.2
|
|
|
|
|
A144
|
|
1-Allyl-3,7-dimethyl-8-phenylxanthine solid
|
149981-23-7
|
296.3
|
|
|
|
|
A145
|
|
1-Allyl-3,7-dimethyl-8-sulfophenylxanthine solid
|
149981-25-9
|
376.4
|
|
|
|
|
A3254
|
|
4-Amino-5-carboxy-2-ethylmercaptopyrimidine
|
89853-87-2
|
199.2
|
|
|
|
|
A4634
|
|
2-Amino-6-chloropurine riboside ≥95%
|
2004-07-1
|
301.7
|
|
|
|
|
A0429
|
|
N4-Aminocytidine ≥95%
|
57294-74-3
|
258.2
|
|
|
|
|
A5525
|
|
5′-Amino-5′-deoxythymidine
|
25152-20-9
|
241.2
|
|
|
|
|
A4754
|
|
4-Amino-1,3-dimethyl-2,6-dioxy-5-nitrosopyrimidine
|
6632-68-4
|
184.2
|
|
|
|
|
A9546
|
|
2-Amino-6-methylmercaptopurine ≥95%
|
1198-47-6
|
181.2
|
|
|
|
|
A3509
|
|
2-Aminopurine ≥99%
|
452-06-2
|
135.1
|
|
|
|
|
A2380
|
|
2-Aminopurine nitrate salt ≥99%
|
51-16-1
|
198.1
|
|
|
|
|
A4044
|
|
2,3′-Anhydrothymidine
|
15981-92-7
|
224.2
|
|
|
|
|
A5534
|
|
N4-Anisoylcytidine
|
28225-17-4
|
377.4
|
|
|
|
|
A1757
|
|
6-Azauracil ≥98%
|
461-89-2
|
113.1
|
|
|
|
|
A1882
|
|
6-Azauridine
|
54-25-1
|
245.2
|
|
|
|
|
11546
|
|
3′-Azido-3′-deoxythymidine ≥99.0% (HPLC)
|
30516-87-1
|
267.2
|
|
|
|
|
11544
|
|
2′-Azido-2′-deoxyuridine ≥98.0% (N)
|
26929-65-7
|
269.2
|
|
|
|
|
B5258
|
|
N6-Benzoyladenine ≥99%
|
4005-49-6
|
239.2
|
|
|
|
|
B4512
|
|
N4-Benzoyl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxycytidine ~98%
|
67219-55-0
|
633.7
|
|
|
|
|
B6272
|
|
8-Bromoadenosine powder
|
2946-39-6
|
346.1
|
|
|
|
|
16132
|
|
8-Bromoadenosine ≥99.0% (HPLC)
|
2946-39-6
|
346.1
|
|
|
|
|
16880
|
|
5-Bromo-2′-deoxyuridine ≥99.0% (HPLC)
|
59-14-3
|
307.1
|
|
|
|
|
17110
|
|
8-Bromoguanosine-3′,5′-cyclomonophosphate sodium salt ≥99.0% (HPLC)
|
51116-01-9
|
446.1
|
|
|
|
|
B8252
|
|
Bromonucleic acid
|
|
|
|
|
|
|
B9502
|
|
8-Bromo-2′,3′,5′-tri-O-acetylguanosine
|
15717-45-0
|
488.3
|
|
|
|
|
18660
|
|
5-Bromouracil ≥95.0% (HPLC)
|
51-20-7
|
191
|
|
|
|
|
B1128
|
|
6-n-Butoxypurine crystalline
|
5454-70-6
|
192.2
|
|
|
|
|
C7000
|
|
5-Carbethoxyuracil ~90%
|
28485-17-8
|
184.2
|
|
|
|
|
C4041
|
|
8-(3-Carboxypropyl)-1,3-dimethylxanthine
|
5438-71-1
|
266.3
|
|
|
|
|
C9375
|
|
5-Carboxy-2-thiouracil
|
23945-50-8
|
172.2
|
|
|
|
|
C7938
|
|
2-Chloro-N6-cyclopentyladenosine adenosine receptor agonist
|
37739-05-2
|
369.8
|
|
|
|
|
C4438
|
|
2-Chloro-2′-deoxyadenosine antileukemic
|
4291-63-8
|
285.7
|
|
|
|
|
C6891
|
|
5-Chloro-2′-deoxyuridine thymidine analog
|
50-90-8
|
262.7
|
|
|
|
|
C8276
|
|
6-Chloropurine riboside
|
5399-87-1
|
286.7
|
|
|
|
|
C9525
|
|
4-Chlorouracil ≥99%
|
4270-27-3
|
146.5
|
|
|
|
|
C5392
|
|
6-Cyanopurine ~90%
|
2036-13-7
|
145.1
|
|
|
|
|
C8039
|
|
1-Cyclohexyluracil powder
|
712-43-6
|
194.2
|
|
|
|
|
C9773
|
|
Cytidylyl(3′→5′)uridine ammonium salt
|
27552-97-2
|
549.4
|
|
|
|
|
D7400
|
|
2′-Deoxyadenosine monohydrate ≥99%
|
16373-93-6
|
269.3
|
|
|
|
|
D1771
|
|
5′-Deoxyadenosine methylthioadenosine/S-adenosylhomocysteine (MTA/SAH) nucleosidase substrate
|
4754-39-6
|
251.2
|
|
|
|
|
D3897
|
|
2′-Deoxycytidine ≥99% (HPLC)
|
951-77-9
|
227.2
|
|
|
|
|
D8143
|
|
2′-Deoxycytidylyl(3′→5′)-2′-deoxyguanosine ammonium salt ~95%
|
77710-57-7
|
556.4
|
|
|
|
|
D7145
|
|
2′-Deoxyguanosine monohydrate 99-100%
|
312693-72-4
|
285.3
|
|
|
|
|
D7285
|
|
3′-Deoxyguanosine
|
3608-58-0
|
267.2
|
|
|
|
|
D5287
|
|
2′-Deoxyinosine ≥98%
|
890-38-0
|
252.2
|
|
|
|
|
D5011
|
|
5′-Deoxy-5′-(methylthio)adenosine
|
2457-80-9
|
297.3
|
|
|
|
|
D5412
|
|
2′-Deoxyuridine 99-100%
|
951-78-0
|
228.2
|
|
|
|
|
D7632
|
|
2′,3′-Di-O-benzoyluridine ≥99% (TLC)
|
50408-20-3
|
452.4
|
|
|
|
|
D1285
|
|
2′,3′-Dideoxyadenosine ≥97% (HPLC)
|
4097-22-7
|
235.2
|
|
|
|
|
36775
|
|
2′,3′-Dideoxycytidine ≥99.0% (HPLC)
|
7481-89-2
|
211.2
|
|
|
|
|
36767
|
|
2′,3′-Dideoxy-5-iodouridine ≥97.0% (HPLC)
|
105784-83-6
|
338.1
|
|
|
|
|
D1897
|
|
5,6-Dihydrodeoxyuridine
|
5626-99-3
|
230.2
|
|
|
|
|
D7279
|
|
5′-O-(4,4′-Dimethoxytrityl)-2′-deoxyuridine
|
23669-79-6
|
530.6
|
|
|
|
|
D5008
|
|
2-Dimethylamino-6-hydroxypurine ≥98%
|
1445-15-4
|
179.2
|
|
|
|
|
D2629
|
|
6-(Dimethylamino)purine ≥98%
|
938-55-6
|
163.2
|
|
|
|
|
D2889
|
|
1,3-Dimethyluric acid
|
944-73-0
|
196.2
|
|
|
|
|
E4007
|
|
1,N6-Ethenoadenine
|
13875-63-3
|
159.2
|
|
|
|
|
E4132
|
|
1,N6-Etheno-2′-deoxyadenosine
|
68498-25-9
|
275.3
|
|
|
|
|
E1126
|
|
6-Ethoxypurine
|
17861-06-2
|
164.2
|
|
|
|
|
E9386
|
|
5-Ethyl-2′-deoxyuridine
|
15176-29-1
|
256.3
|
|
|
|
|
E4267
|
|
9-Ethylguanine
|
879-08-3
|
179.2
|
|
|
|
|
E4126
|
|
6-Ethylmercaptopurine
|
5417-84-5
|
180.2
|
|
|
|
|
F9128
|
|
5′-(4-Fluorosulfonylbenzoyl)adenosine hydrochloride
|
78859-42-4
|
489.9
|
|
|
|
|
F6256
|
|
5-Fluoro-1-(tetrahydro-2-furyl)uracil
|
17902-23-7
|
200.2
|
|
|
|
|
F5130
|
|
5-Fluorouridine proapoptotic anitproliferative plant growth regulator
|
316-46-1
|
262.2
|
|
|
|
|
47580
|
|
5-Fluorouridine ≥99.0% (HPLC)
|
316-46-1
|
262.2
|
|
|
|
|
G2785
|
|
Glycitein ≥97% (HPLC)
|
40957-83-3
|
284.3
|
|
|
|
|
G6752
|
|
Guanosine ≥98%
|
118-00-3
|
283.2
|
|
|
|
|
G9011
|
|
Guanylyl(2′→5′)adenosine ammonium salt
|
103192-47-8
|
629.5
|
|
|
|
|
G1506
|
|
Guanylyl(3′→5′)cytidine ammonium salt
|
98046-67-4
|
605.5
|
|
|
|
|
G9502
|
|
Guanylyl(3′→5′)uridine ammonium salt
|
41547-83-5
|
606.4
|
|
|
|
|
H4000
|
|
6-n-Heptylmercaptopurine crystalline
|
83277-80-9
|
250.4
|
|
|
|
|
H8631
|
|
5-Hydroxymethyl-2′-deoxyuridine ≥95% (HPLC)
|
5116-24-5
|
258.2
|
|
|
|
|
H5398
|
|
S-(2-Hydroxy-5-nitrobenzyl)-6-thioguanosine ≥90% (TLC)
|
41094-07-9
|
450.4
|
|
|
|
|
H8260
|
|
S-(2-Hydroxy-5-nitrobenzyl)-6-thioinosine
|
56964-73-9
|
435.4
|
|
|
|
|
H9377
|
|
Hypoxanthine ≥99%
|
68-94-0
|
136.1
|
|
|
|
|
I6893
|
|
Indoxyl β-D-glucoside BioXtra, ≥97%
|
487-60-5
|
295.3
|
|
|
|
|
I6875
|
|
5-Iodocytosine
|
1122-44-7
|
237
|
|
|
|
|
I7000
|
|
5-Iodo-2′-deoxycytidine
|
611-53-0
|
353.1
|
|
|
|
|
I8766
|
|
5-Iodo-2,4-dimethoxypyrimidine ≥98% (TLC)
|
52522-99-3
|
266
|
|
|
|
|
58150
|
|
5-Iodouridine ≥97.0% (HPLC)
|
1024-99-3
|
370.1
|
|
|
|
|
I2260
|
|
N2-Isobutyryl-3′-O-benzoyl-2′-deoxyguanosine ~98%
|
63660-23-1
|
441.4
|
|
|
|
|
I6632
|
|
N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine ~98%
|
68892-41-1
|
639.7
|
|
|
|
|
I6508
|
|
N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine 3′-O-succinic acid ~95%
|
74405-46-2
|
739.8
|
|
|
|
|
I2127
|
|
Isocytosine ≥99%
|
108-53-2
|
111.1
|
|
|
|
|
I4377
|
|
2′,3′-O-Isopropylideneguanosine
|
362-76-5
|
323.3
|
|
|
|
|
I4627
|
|
2′,3′-O-Isopropylidene-6-mercaptopurine riboside
|
5856-48-4
|
324.4
|
|
|
|
|
I5127
|
|
2′,3′-O-Isopropylideneuridine ≥99% (HPLC)
|
362-43-6
|
284.3
|
|
|
|
|
I7388
|
|
Isoxanthopterin ≥97.5%, powder
|
529-69-1
|
179.1
|
|
|
|
|
K3000
|
|
Kinetin riboside proapoptotic anitproliferative plant growth regulator
|
4338-47-0
|
347.3
|
|
|
|
|
M6875
|
|
2-Mercaptopurine ≥95%, crystalline
|
28128-19-0
|
152.2
|
|
|
|
|
M5628
|
|
6-Mercaptopurine-2′-deoxyriboside
|
2239-64-7
|
268.3
|
|
|
|
|
M9261
|
|
5-Methoxyuridine
|
35542-01-9
|
274.2
|
|
|
|
|
M9281
|
|
3-Methyladenine autophagy inhibitor
|
5142-23-4
|
149.2
|
|
|
|
|
M9886
|
|
2′-O-Methyladenosine
|
2140-79-6
|
281.3
|
|
|
|
|
M4254
|
|
5-Methylcytidine ≥99%
|
2140-61-6
|
257.2
|
|
|
|
|
M6751
|
|
5-Methylcytosine hydrochloride ≥99%
|
58366-64-6
|
161.6
|
|
|
|
|
M2389
|
|
N6-Methyl-2′-deoxyadenosine
|
2002-35-9
|
265.3
|
|
|
|
|
M4004
|
|
N2-Methylguanosine ~95%
|
2140-77-4
|
297.3
|
|
|
|
|
M0627
|
|
7-Methylguanosine ≥90%
|
20244-86-4
|
297.3
|
|
|
|
|
M4002
|
|
6-Methylmercaptopurine riboside ≥99% (HPLC)
|
342-69-8
|
298.3
|
|
|
|
|
M6502
|
|
6-Methylpurine ≥99%
|
2004-03-7
|
134.1
|
|
|
|
|
M8012
|
|
5-Methyl-2-thiouridine
|
32738-09-3
|
274.3
|
|
|
|
|
M7636
|
|
1-Methylthymine
|
4160-72-9
|
140.1
|
|
|
|
|
M4508
|
|
4-Methylumbelliferyl β-L-fucoside glycosidase substrate
|
72601-82-2
|
322.3
|
|
|
|
|
M6631
|
|
3-Methyluracil
|
608-34-4
|
126.1
|
|
|
|
|
M6885
|
|
1-Methyluric acid
|
708-79-2
|
182.1
|
|
|
|
|
M4262
|
|
3′-O-Methyluridine
|
6038-59-1
|
258.2
|
|
|
|
|
M8905
|
|
5-Methyluridine powder
|
1463-10-1
|
258.2
|
|
|
|
|
O5508
|
|
N4-Octadecylcytosine β-D-arabinofuranoside
|
158233-67-1
|
495.7
|
|
|
|
|
O2875
|
|
Orotic acid potassium salt ≥99%
|
24598-73-0
|
194.2
|
|
|
|
|
O9505
|
|
Orotidine ≥90% (HPLC)
|
314-50-1
|
288.2
|
|
|
|
|
O6881
|
|
Oxypurinol ≥98% (HPLC)
|
2465-59-0
|
152.1
|
|
|
|
|
P201
|
|
R(−)-PD 128,908 hydrochloride >97%, solid
|
|
285.8
|
|
|
|
|
P9204
|
|
N6-Phenoxyacetyl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyadenosine
|
115388-94-8
|
687.7
|
|
|
|
|
P3252
|
|
6-Phenyl-2-thiouracil ≥95%
|
36822-11-4
|
204.3
|
|
|
|
|
P4404
|
|
Polyguanylic acid potassium salt lyophilized powder
|
54684-83-2
|
|
|
|
|
|
P6905
|
|
Polythymidylic acid sodium salt homopolymer
|
85597-60-0
|
|
|
|
|
|
P3005
|
|
6-n-Propoxypurine ≥99%
|
5417-86-7
|
178.2
|
|
|
|
|
P0643
|
|
5-Propyl-2-thiouracil ≥98%
|
2954-52-1
|
170.2
|
|
|
|
|
P3755
|
|
6-Propyl-2-thiouracil enzyme inhibitor
|
51-52-5
|
170.2
|
|
|
|
|
P8419
|
|
5-n-Propyluracil
|
19030-75-2
|
154.2
|
|
|
|
|
S4000
|
|
6-Selenopurine
|
5270-30-4
|
199.1
|
|
|
|
|
N1134
|
|
Se-(p-Nitrobenzyl)-6-selenoinosine ≥95%
|
40144-12-5
|
466.3
|
|
|
|
|
S9126
|
|
5-Sulfaminouracil ~95%
|
5435-16-5
|
207.2
|
|
|
|
|
T7750
|
|
2-Thiouracil ≥99%
|
141-90-2
|
128.2
|
|
|
|
|
T4509
|
|
4-Thiouridine ≥98%
|
13957-31-8
|
260.3
|
|
|
|
|
T7266
|
|
Thymidylyl(3′→5′)-2′-deoxyadenosine ammonium salt
|
61845-39-4
|
570.5
|
|
|
|
|
T8880
|
|
Thymidylyl(3′→5′)thymidine ammonium salt
|
1969-54-6
|
563.5
|
|
|
|
|
T3766
|
|
Thymine 1-β-D-arabinofuranoside ≥99%
|
605-23-2
|
258.2
|
|
|
|
|
T7895
|
|
2′,3′,5′-Tri-O-acetyladenosine ≥98%
|
7387-57-7
|
393.4
|
|
|
|
|
T5626
|
|
2′,3′,5′-Tri-O-acetylcytidine hydrochloride
|
63639-21-4
|
405.8
|
|
|
|
|
T6001
|
|
2′,3′,5′-Tri-O-acetyluridine ≥98%
|
4105-38-8
|
370.3
|
|
|
|
|
T7126
|
|
4,5,6-Triaminopyrimidine sulfate powder
|
49721-45-1
|
223.2
|
|
|
|
|
T8501
|
|
2′,3′,5′-Tri-O-benzoyluridine
|
1748-04-5
|
556.5
|
|
|
|
|
T8130
|
|
9-(2′,3′,5′-Tri-O-benzyl-β-D-arabinofuranosyl)adenine
|
3257-73-6
|
537.6
|
|
|
|
|
T2255
|
|
Trifluorothymidine ≥99% (HPLC)
|
70-00-8
|
296.2
|
|
|
|
|
T4146
|
|
1,3,9-Trimethylxanthine ≥98% (HPLC), solid
|
519-32-4
|
194.2
|
|
|
|
|
T1159
|
|
5′-O-Tritylthymidine ~98%
|
7791-71-1
|
484.5
|
|
|
|
|
U5377
|
|
Uracil 1-β-D-arabinofuranoside lymphoma antiproliferative
|
3083-77-0
|
244.2
|
|
|
|
|
Z0751
|
|
Zeatin riboside mixed Isomers ~95%
|
28542-78-1
|
351.4
|
|
|
|